产品名称 | NebuSelect™ Recombinant Cynomolgus SFRP2, His-tag |
---|---|
目录号 | NBL-241914 |
别名 | SFRP2 |
外观 | see COA |
分子量 | Leu25-Cys295 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | G8F2Z7 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241914-100ug | 100ug | Inquire | Inquire | |
NBL-241914-1mg | 1mg | Inquire | Inquire | |
NBL-241914-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus SFRP2, His-tag
Catalog#:
NBL-241914
Description:
NebuSelect™ Recombinant Cynomolgus SFRP2, His-tag(Cat#NBL-241914) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu25-Cys295.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.16 kDa. Due to glycosylation, the protein migrates to 33-38 kDa based on Bis-Tris PAGE result.
Target Name:
SFRP2
Target Information:
As biomarkers, DNA methylation is used to detect colorectal cancer (CRC) and make assessment of CRC prognosis. The published findings showed the association between the methylation of SFRP1, SFRP2, and WIF1, located in the Wnt signaling pathway, and the prognosis of CRC were not consistent. SFRP1, SFRP2, and WIF1 were frequently hypermethylated in CRC tumor tissues. It was apparent that the promoter hypermethylation of SFRP2 and co-hypermethylation of SFRP1 and SFRP2 might be considered as independent prognostic predictors for survival advantage of postoperative CRC patients.
Amino Acid Sequence:
Leu25-Cys295
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.